https://doi.org/10.1016/s0140-6736(22)00688-2
N
Nanne K.H. de Boer
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
519
Papers
9.5K
Citations
49
h-index
204
i10-index
Nanne K.H. de Boer is an academic researcher from Amsterdam Neuroscience. The author has contributed to research in topics: Inflammatory Bowel Disease & Acute Lymphoblastic Leukemia research & Microscopic Colitis. The author has an h-index of 49, co-authored 442 publications.
ORCID: 0000-0001-8357-9887Papers by this author
worksUstekinumab versus adalimumab for induction and maintenance therapy in biologic-naive patients with moderately to severely active Crohn's disease: a multicentre, randomised, double-blind, parallel-group, phase 3b trial
2022 · The Lancet · 277 citations
The influence of prenatal and intrapartum antibiotics on intestinal microbiota colonisation in infants: A systematic review
2020 · Journal of Infection · 113 citations
https://doi.org/10.1016/j.jinf.2020.05.002
Long-Term Follow-Up of Transgender Women After Secondary Intestinal Vaginoplasty
2016 · The Journal of Sexual Medicine · 100 citations
https://doi.org/10.1016/j.jsxm.2016.01.008
Risk Factors for Late-Onset Sepsis in Preterm Infants: A Multicenter Case-Control Study
2019 · Neonatology · 92 citations
https://doi.org/10.1159/000497781
Tofacitinib for ulcerative colitis: results of the prospective Dutch Initiative on Crohn and Colitis (ICC) registry
2020 · Alimentary Pharmacology & Therapeutics · 85 citations
https://doi.org/10.1111/apt.15689
Finding hidden treasures in old drugs: the challenges and importance of licensing generics
2017 · Drug Discovery Today · 69 citations
https://doi.org/10.1016/j.drudis.2017.08.008
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat